Evolocumab - Amgen
At a glance
- Drug Originator Amgen
- Drug Licenced by Clinigen; Dr Reddys Laboratories
- Drug Class Anti-ischaemics; Antihyperlipidaemics; Monoclonal antibodies; Vascular disorder therapies
- Mechanism of Action PCSK9 protein inhibitors
- USA Patent Applicants AMGEN INC
- USA Patents 27
- BLAs 1
- International Patents 376
Disclaimer